wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36318871-540B6660-07A4-468C-8004-D4BF160722B4
Q36318871-540B6660-07A4-468C-8004-D4BF160722B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36318871-540B6660-07A4-468C-8004-D4BF160722B4
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.
P2860
Q36318871-540B6660-07A4-468C-8004-D4BF160722B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36318871-540B6660-07A4-468C-8004-D4BF160722B4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
62b5e7418e3415f446b701eee7f08121de3e064f
P2860
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.